Artery sheathing canal fixing device
By designing an arterial sheath fixation device, which utilizes a combination of hemostatic fixation components and a hemostatic layer, the problem of unstable fixation of the arterial sheath is solved, the risk of bleeding is reduced, and the hemostatic effect and fixation stability are improved.
Patent Information
- Application Number
- CN202422280309.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-18
- Publication Date
- 2025-12-09
- Estimated Expiration
- 2034-09-18
AI Technical Summary
The lack of effective arterial sheath fixation devices in the current technology leads to a high risk of bleeding, poor fixation effect, and the risk of catheter displacement if bleeding is not treated in time, causing inconvenience to patients.
An arterial sheath fixation device was designed, including a hemostatic fixation component and an arterial sheath. The hemostatic fixation component is a disc-shaped structure with an internal placement groove that covers the sheath connection. Combined with the hemostatic layer and the through-channel, it provides fixation and compression hemostasis functions, reducing the risk of bleeding.
It improves the fixation effect between the arterial sheath and the human skin, reduces the risk and amount of bleeding, increases the local pressure effect, and improves the hemostasis efficiency.
Smart Images
Figure CN223641120U_ABST
Abstract
Description
Technical Field
[0001] This utility model belongs to the field of medical device technology, specifically relating to an arterial sheath fixation device. Background Technology
[0002] Transcatheter hepatic artery infusion chemotherapy is a common treatment for patients with unresectable or palliative liver cancer. The catheter is typically advanced via the femoral artery to a designated location, and chemotherapy drugs are then continuously infused through an arterial sheath. To reduce chemotherapy-related adverse reactions, maintenance infusion is routinely performed using an infusion pump, with continuous treatment lasting 48-72 hours. The arterial sheath is removed only after treatment is completed.
[0003] Due to high arterial pressure, complete immobilization of the patient's lower limbs is difficult. Combined with adverse reactions from chemotherapy drugs, significant bleeding occurs at the arterial sheath. Because of concerns that managing bleeding and changing dressings might affect the sheath's position, dressing changes and bleeding management require returning the patient to the interventional radiology room. This frequently results in delayed bleeding management, posing a significant risk of catheter displacement and causing considerable inconvenience to the patient. Currently, there is no suitable arterial sheath fixation device; only transparent dressings are used for fixation. However, the fixation effectiveness is greatly reduced when there is bleeding within the transparent dressing.
[0004] Therefore, how to provide a fixation device specifically for arterial sheaths to improve the fixation effect between the arterial sheath and human skin, prevent the displacement of the arterial sheath, increase the local pressure effect, and reduce the risk of bleeding is a technical problem that urgently needs to be solved by those skilled in the art. Utility Model Content
[0005] The technical problem to be solved by this utility model is to provide an arterial sheath fixation device, so as to solve at least one of the above-mentioned technical problems.
[0006] To solve the above-mentioned technical problems, this utility model provides an arterial sheath fixation device, which includes: an arterial sheath, the arterial sheath including a sheath connection part, an arterial sheath, a sheath core, and a three-way valve; the sheath connection part includes a first end, a second end, and a third end, one end of the arterial sheath is connected to the first end, and the other end of the arterial sheath is connected to the sheath core; the three-way valve is connected to the second end through an extension tube, and the third end is provided with a protruding structure; wherein, the setting direction of the first end and the setting direction of the third end are in the same straight line, and the setting direction of the second end is perpendicular to the setting directions of the first end and the second end; a hemostatic fixation member, the hemostatic fixation member having a disc-shaped structure with an internal placement groove, the hemostatic fixation member covering the sheath connection part.
[0007] Optionally, the hemostatic fixing member includes a shell and a hemostatic layer. The shell has a semi-enclosed structure, and the hemostatic layer fills the shell. The placement groove is formed in the hemostatic layer, and the size of the placement groove is adapted to the size of the sheath connection, so that the placement groove covers and surrounds the sheath connection.
[0008] Optionally, the hemostatic fixing member further includes a first through channel and a second through channel, both of which penetrate the outer shell and the hemostatic layer and are connected to the placement groove.
[0009] Optionally, the orientation of the first through channel is perpendicular to the orientation of the second through channel; the size of the first through channel is adapted to the size of the protruding structure, and the size of the second through channel is adapted to the size of the second end and the extension tube.
[0010] Optionally, the hemostatic fixation member also has a shallow opening, which is connected to the placement groove; the opening position of the shallow opening is in the same direction as the setting direction of the first through channel.
[0011] Optionally, the hemostatic layer is made of medical absorbent dressing.
[0012] Optionally, the hemostatic fixation device further includes a plurality of fixation stickers, one end of which is bonded to the outer shell, and the other end of which is bonded to human skin.
[0013] Optionally, the hemostatic fixation component further includes an adhesive disc integrally formed with the housing, the adhesive ring being arranged around the bottom of the outer side of the housing.
[0014] Optionally, the bonding pad includes a first half-ring and a second half-ring, which are separated by a first through channel and a second through channel, respectively; the curvature of the second half-ring is greater than that of the first half-ring, and a connecting groove is provided at the junction of the second half-ring and the shallow opening, the connecting groove being connected to the shallow opening.
[0015] Optionally, a plurality of ventilation holes are uniformly provided through the first half-ring and the second half-ring, and a non-woven adhesive layer is provided on the inner surface of the first half-ring and the second half-ring, and the non-woven adhesive layer is bonded to human skin.
[0016] Beneficial effects:
[0017] This utility model provides an arterial sheath fixation device, including an arterial sheath and a hemostatic fixation component. The arterial sheath includes a sheath connection portion, an arterial sheath, a sheath core, and a three-way valve. The arterial sheath and the three-way valve are respectively connected to a first end and a second end of the sheath connection portion, and the sheath core is connected to the other end of the arterial sheath. In use, both the arterial sheath and the sheath core are punctured into the patient's artery. A protruding structure is provided at the third end. The hemostatic fixation component is a disc-shaped cover structure with an internal groove. By making the hemostatic fixation component a disc-shaped cover structure, the sheath connection portion and the connected arterial sheath and extension tube are covered and protected. The hemostatic fixation device has a groove designed inside based on the shape of the sheath connection and the connected arterial sheath and extension tube. The hemostatic fixation device is placed on the sheath connection to ensure that the arterial sheath cannot move within the fixation device. In this way, a fixation device specifically for arterial sheaths is constructed, which improves the fixation effect between the arterial sheath and the human skin, avoids the displacement of the arterial sheath, reduces the risk and amount of bleeding caused by catheter displacement, and can also apply pressure to the arterial sheath by pressing the hemostatic fixation device on it to stop bleeding, increase the local pressure effect, and absorb some of the bleeding, thereby improving the hemostatic effect.
[0018] The above description is merely an overview of the technical solution of this utility model. In order to better understand the technical means of this utility model and to implement it in accordance with the contents of the specification, and to make the above and other objects, features and advantages of this utility model more obvious and understandable, specific embodiments of this utility model are given below. Attached Figure Description
[0019] To more clearly illustrate the technical solutions in the embodiments of this specification or the prior art, the drawings used in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of this utility model. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.
[0020] Figure 1 This is a schematic diagram of the overall structure of the arterial sheath fixation device provided in the embodiments of this application;
[0021] Figure 2 This is a schematic diagram of the overall structure of the arterial sheath provided in the embodiments of this application;
[0022] Figure 3 This is a schematic diagram of the hemostatic fixation component provided in the embodiments of this application;
[0023] Figure 4 This is a schematic diagram of the hemostatic fixation component provided in the embodiments of this application;
[0024] Figure label:
[0025] 1—Arterial sheath;
[0026] 11—Sheath connection;
[0027] 111—First end;
[0028] 112—Second end;
[0029] 113—Third end;
[0030] 12—Arterial sheath;
[0031] 13—Sheath core;
[0032] 14—Three-way valve;
[0033] 15—Extension tube;
[0034] 2—Hemostatic fixation device;
[0035] 21—Outer shell;
[0036] 22—Hemostatic layer;
[0037] 23—First through passage;
[0038] 24—Second through passage;
[0039] 25—Shallow mouth;
[0040] 26—Adhesive disc;
[0041] 261—First Half Ring;
[0042] 262—Second Half Ring;
[0043] 263—ventilation hole;
[0044] 264—Non-woven adhesive layer; Detailed Implementation
[0045] The technical solutions of the present utility model will be clearly and completely described below with reference to the accompanying drawings of the embodiments. Obviously, the described embodiments are only some embodiments of the present utility model, and not all embodiments. Based on the embodiments of the present utility model, all other embodiments obtained by those of ordinary skill in the art without creative effort are within the protection scope of the present utility model.
[0046] Furthermore, in the embodiments of this specification, when a component is referred to as being "fixed to" another component, it can be directly on the other component or there may be an intervening component. When a component is considered to be "connected to" another component, it can be directly connected to the other component or there may be an intervening component. When a component is considered to be "set on" another component, it can be directly set on the other component or there may be an intervening component. The terms "vertical," "horizontal," "left," "right," and similar expressions used in the embodiments of this specification are for illustrative purposes only and are not intended to limit the present invention.
[0047] Please see Figure 1-3 This embodiment provides an arterial sheath fixation device, which includes: an arterial sheath 1, the arterial sheath including a sheath connection part 11, an arterial sheath 12, a sheath core 13, and a three-way valve 14; the sheath connection part 11 includes a first end 111, a second end 112, and a third end 113, one end of the arterial sheath 12 is connected to the first end 111, and the other end of the arterial sheath 12 is connected to the sheath core 13; the three-way valve 14 is connected to the second end 112 through an extension tube 15, and the third end 113 is provided with a protruding structure; wherein, the setting direction of the first end 111 and the setting direction of the third end 113 are in the same straight line, and the setting direction of the second end 112 is perpendicular to the setting directions of the first end 111 and the second end 112; a hemostatic fixation member 2, which is a disc-shaped structure with an internal placement groove, and is placed on the sheath connection part 11.
[0048] Specifically, this utility model provides an arterial sheath fixation device, including an arterial sheath 1 and a hemostatic fixation component 2. The arterial sheath 1 includes a sheath connection portion 11, an arterial sheath 12, a sheath core 13, and a three-way valve 14. The arterial sheath 12 and the three-way valve 14 are respectively connected to the first end 111 and the second end 112 of the sheath connection portion 11. The sheath core 13 is connected to the other end of the arterial sheath 12. In use, both the arterial sheath 12 and the sheath core 13 are punctured into the patient's artery. The third end 113 is provided with a protruding structure. The hemostatic fixation component 2 is a disc-shaped structure with an internal groove. By setting the hemostatic fixation component 2 as a disc-shaped structure, the sheath connection portion 11 and the arterial sheath 12 connected to it are fixed in place. The arterial sheath 12 and extension tube 15 are covered and protected. The hemostatic fixing component 2 is designed with a groove inside according to the shape of the sheath connection part 11 and the arterial sheath 12 and extension tube 15 connected to it. The hemostatic fixing component 2 is covered on the sheath connection part 11 to ensure that the arterial sheath 1 cannot move within the fixing device. In this way, a fixing device specifically for the arterial sheath 1 is constructed, which improves the fixing effect between the arterial sheath 1 and the human skin, avoids the displacement of the arterial sheath 1, reduces the risk and amount of bleeding caused by catheter displacement, and can also compress and stop bleeding by covering and pressing the hemostatic fixing component 2 on the arterial sheath 1, increasing the local pressure effect, and absorbing a certain amount of bleeding to improve the hemostatic effect.
[0049] In some possible embodiments, the hemostatic fixing member 2 includes a housing 21 and a hemostatic layer 22. The housing 21 has a semi-enclosed structure, and the hemostatic layer 22 fills the housing 21. A placement groove is formed in the hemostatic layer 22, and the size of the placement groove is adapted to the size of the sheath connection 11 so that the placement groove covers and surrounds the sheath connection 11.
[0050] Specifically, the outer shell 21 protects the sheath connection 11 and its connected extension tubes and sheaths, preventing bleeding at the puncture site due to compression. The hemostatic layer 22 helps absorb the bleeding and also serves as an auxiliary tool for applying local pressure to prevent bleeding at the puncture site. In this way, the arterial puncture site is protected, hemostatic and bleeds are absorbed from both inside and outside, improving hemostasis efficiency.
[0051] In some possible implementations, the hemostatic fixing member 2 also includes a first through channel 23 and a second through channel 24, both of which are opened through the outer shell 21 and the hemostatic layer 22 and are connected to the placement groove.
[0052] Specifically, the protruding structure of the sheath connection 11 and the second end 112 are provided to pass through the opening of the first through channel 23 and the second through channel 24.
[0053] In some possible implementations, the orientation of the first through channel 23 is perpendicular to the orientation of the second through channel 24; the size of the first through channel 23 is adapted to the size of the protrusion structure, and the size of the second through channel 24 is adapted to the size of the second end 112 and the extension tube 15.
[0054] In some possible implementations, the hemostatic fixing member 2 is further provided with a shallow opening 25, which is connected to the placement groove; the opening position of the shallow opening 25 is in the same direction as the setting direction of the first through channel 23.
[0055] Specifically, since both the arterial sheath 12 and the sheath core 13 are punctured into the patient's artery during use, the connection between the arterial sheath 12 and the first end 111 is partially exposed, and the connection between the arterial sheath 12 and the first end 111 is the main bleeding point, the shallow opening 25 is used to cover the exposed part of the arterial sheath 12 to avoid excessive compression, and at the same time, it can absorb blood.
[0056] In some possible implementations, the hemostatic layer 22 is made of medical absorbent dressing.
[0057] Specifically, the hemostatic layer 22 is made of a soft medical dressing with good water absorption. On the one hand, it can help absorb blood seepage, and on the other hand, it serves as an auxiliary tool for applying local pressure to prevent blood seepage at the puncture site.
[0058] In some possible implementations, the hemostatic fixation member 2 also includes a plurality of fixation stickers, one end of which is bonded to the outer shell 21 and the other end of which is bonded to human skin.
[0059] Specifically, by setting several fixing stickers, the hemostatic fixing component 2 is fixed to the human skin as a whole. As one possible method, four fixing stickers can be set and the four fixing stickers are respectively attached to the top of the outer shell 21, forming a cross-shaped fixing structure.
[0060] In some possible implementations, the hemostatic fixation member 2 may also include an adhesive pad 26 integrally formed with the housing 21, the adhesive pad 26 being arranged around the bottom of the outer side of the housing 21.
[0061] Specifically, the adhesive plate 26 facilitates the bonding of the hemostatic fixation piece 2 to the human skin when no fixation tape is available.
[0062] In some possible implementations, the bonding pad 26 includes a first half-ring 261 and a second half-ring 262, which are separated by a first through channel 23 and a second through channel 24, respectively. The curvature of the second half-ring 262 is greater than that of the first half-ring 261. A connecting groove is provided at the junction of the second half-ring 262 and the shallow opening 25, and the connecting groove is connected to the shallow opening 25.
[0063] Specifically, such as Figure 4 As shown, the adhesive disc 26 includes a first half-ring 261 and a second half-ring 262, and the first half-ring 261 and the second half-ring 262 are staggered from the first through channel 23 and the second through channel 24 to avoid pressing on the arterial sheath (12) and the protruding structure; at the same time, a connecting groove connected to the shallow opening 25 is also provided, so as to further fix the exposed part of the arterial sheath 12 through the connecting groove.
[0064] In some possible implementations, a plurality of ventilation holes 263 are uniformly provided through the first half-ring 261 and the second half-ring 262, and a non-woven adhesive layer 264 is provided on the inner side of the first half-ring 261 and the second half-ring 262, and is bonded to human skin through the non-woven adhesive layer 264.
[0065] Specifically, the adhesion stability with human skin is improved through the air pores 263 and the non-woven adhesive layer 264.
[0066] Finally, it should be noted that the above embodiments are merely specific implementations of this utility model, used to illustrate the technical solution of this utility model, and not to limit it. The protection scope of this utility model is not limited thereto. Although this utility model has been described in detail with reference to the foregoing embodiments, those skilled in the art should understand that any person skilled in the art can still modify or easily conceive of changes to the technical solutions described in the foregoing embodiments, or make equivalent substitutions for some of the technical features, within the technical scope disclosed in this utility model; and these modifications, changes, or substitutions do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of this utility model. All should be covered within the protection scope of this utility model. Therefore, the protection scope of this utility model should be determined by the protection scope of the claims.
[0067] Although the embodiments of this utility model have been disclosed above, they are not limited to the applications listed in the specification and embodiments. They can be applied to various fields suitable for this utility model. For those skilled in the art, other modifications can be easily made. Therefore, without departing from the general concept defined by the claims and their equivalents, this utility model is not limited to the specific details and the illustrations shown and described herein.
Claims
1. An arterial sheath fixation device, characterized in that, The arterial sheath fixation device includes: An arterial sheath (1) includes a sheath connection (11), an arterial sheath (12), a sheath core (13), and a three-way valve (14). The sheath connection (11) includes a first end (111), a second end (112), and a third end (113). One end of the arterial sheath (12) is connected to the first end (111), and the other end of the arterial sheath (12) is connected to the sheath core (13). The three-way valve (14) is connected to the second end (112) through an extension tube (15), and the third end (113) is provided with a protruding structure. The first end (111) is aligned with the third end (113) in a straight line, and the second end (112) is perpendicular to both the first end (111) and the second end (112). The hemostatic fixing component (2) is a disc-shaped structure with an internal groove for placement, and is placed on the sheath connection part (11).
2. The arterial sheath fixation device according to claim 1, characterized in that, The hemostatic fixing member (2) includes a shell (21) and a hemostatic layer (22). The shell (21) has a semi-enclosed structure, and the hemostatic layer (22) is filled inside the shell (21). The placement groove is formed inside the hemostatic layer (22), and the size of the placement groove is adapted to the size of the sheath connection part (11) so that the placement groove covers and surrounds the sheath connection part (11).
3. The arterial sheath fixation device according to claim 2, characterized in that, The hemostatic fixing component (2) further includes a first through channel (23) and a second through channel (24), both of which penetrate the outer shell (21) and the hemostatic layer (22) and are connected to the placement groove.
4. The arterial sheath fixation device according to claim 3, characterized in that, The orientation of the first through channel (23) is perpendicular to the orientation of the second through channel (24); the size of the first through channel (23) is adapted to the size of the protruding structure, and the size of the second through channel (24) is adapted to the size of the second end (112) and the extension tube (15).
5. The arterial sheath fixation device according to claim 4, characterized in that, The hemostatic fixing member (2) is also provided with a shallow opening (25), which is connected to the placement groove; the opening position of the shallow opening (25) is in the same direction as the setting direction of the first through channel (23).
6. The arterial sheath fixation device according to claim 5, characterized in that, The hemostatic layer (22) is made of medical absorbent dressing.
7. The arterial sheath fixation device according to claim 6, characterized in that, The hemostatic fixation component (2) also includes several fixation stickers, one end of which is bonded to the outer shell (21), and the other end of which is bonded to human skin.
8. The arterial sheath fixation device according to claim 7, characterized in that, The hemostatic fixation member (2) also includes an adhesive disc (26) integrally formed with the outer shell (21), the adhesive disc (26) being arranged around the bottom of the outer side of the outer shell (21).
9. The arterial sheath fixation device according to claim 8, characterized in that, The bonding pad (26) includes a first half-ring (261) and a second half-ring (262), which are separated by the first through channel (23) and the second through channel (24), respectively. The arc of the second half-ring (262) is greater than that of the first half-ring (261), and a connecting groove is provided at the junction of the second half-ring (262) and the shallow opening (25), which is connected to the shallow opening (25).
10. The arterial sheath fixation device according to claim 9, characterized in that, The first half-ring (261) and the second half-ring (262) are evenly perforated with a number of ventilation holes (263). The inner surfaces of the first half-ring (261) and the second half-ring (262) are provided with non-woven adhesive layers (264), and are bonded to human skin through the non-woven adhesive layers (264).